Cargando…

Early Detection Biomarkers for Ovarian Cancer

Despite the widespread use of conventional and contemporary methods to detect ovarian cancer development, ovarian cancer remains a common and commonly fatal gynecological malignancy. The identification and validation of early detection biomarkers highly specific to ovarian cancer, which would permit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarojini, Sreeja, Tamir, Ayala, Lim, Heejin, Li, Shihong, Zhang, Shifang, Goy, Andre, Pecora, Andrew, Suh, K. Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540796/ https://www.ncbi.nlm.nih.gov/pubmed/23319948 http://dx.doi.org/10.1155/2012/709049

Ejemplares similares

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer
por: Tamir, Ayala, et al.
Publicado: (2016)

Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine
por: Suh, K. Stephen, et al.
Publicado: (2013)

Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
por: Gharbaran, Rajendra, et al.
Publicado: (2013)

Molecular Biomarkers for the Early Detection of Ovarian Cancer
por: Zhang, Ruiqian, et al.
Publicado: (2022)

Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
por: Inamdar, Arati A., et al.
Publicado: (2016)

A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes
por: Sarojini, Sreeja, et al.
Publicado: (2015)

New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer
por: Hossain, K. R., et al.
Publicado: (2022)

Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine
por: Castaneda, Christian, et al.
Publicado: (2015)

Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine
por: Nagpal, Poonam, et al.
Publicado: (2016)

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
por: Su, Feng, et al.
Publicado: (2007)

Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?
por: Grayson, Kelly, et al.
Publicado: (2019)

Protein Z: A putative novel biomarker for early detection of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
por: Tcherkassova, Janneta, et al.
Publicado: (2011)

The Value of Ultrasound Monitoring of Adnexal Masses for Early Detection of Ovarian Cancer
por: Suh-Burgmann, Elizabeth, et al.
Publicado: (2016)

Synergetic effect of high dose rate radiations (10× FFF/2400 MU/min/10 MV x‐rays) and paclitaxel selectively eliminates melanoma cells
por: Lodhi, Niraj, et al.
Publicado: (2022)

Detection of early stage ovarian cancer in a large community cohort
por: Suh‐Burgmann, Elizabeth J., et al.
Publicado: (2019)

Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer
por: Mukama, Trasias, et al.
Publicado: (2022)

Protein calorie malnutrition, nutritional intervention and personalized cancer care
por: Gangadharan, Anju, et al.
Publicado: (2017)

Early Detection of Ovarian Cancer
por: Badgwell, Donna, et al.
Publicado: (2007)

Early detection of ovarian cancer
por: Forstner, Rosemarie
Publicado: (2020)

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer
por: Weiland, Florian, et al.
Publicado: (2020)

Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
por: Rogmans, Christoph, et al.
Publicado: (2022)

Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
por: Kim, Yong-Wan, et al.
Publicado: (2012)

Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer
por: Trinidad, Camille V., et al.
Publicado: (2023)

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
por: Shapira, I, et al.
Publicado: (2014)

Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer
por: Trinidad, Camille, et al.
Publicado: (2023)

Nanobodies for the Early Detection of Ovarian Cancer
por: Tran, Lan-Huong, et al.
Publicado: (2022)

ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
por: Rogmans, Christoph, et al.
Publicado: (2021)

Early detection of ovarian cancer: preliminary results of the Yale Early Detection Program.
por: Schwartz, P. E., et al.
Publicado: (1991)

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
por: Chatterjee, Madhumita, et al.
Publicado: (2017)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
por: De La Franier, Brian, et al.
Publicado: (2020)

Electrochemical and Photoelectrochemical Immunosensors for the Detection of Ovarian Cancer Biomarkers
por: Ekwujuru, Ezinne U., et al.
Publicado: (2023)

Circulating biomarkers for early detection of hepatocellular carcinoma
por: Beudeker, Boris J. B., et al.
Publicado: (2020)

Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
por: Schwartz, P. E., et al.
Publicado: (1991)

Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations
por: Kou, Ruqin, et al.
Publicado: (2016)

Next steps in the early detection of ovarian cancer
por: Bast, Robert C., et al.
Publicado: (2021)

Mucins as Potential Biomarkers for Early Detection of Cancer
por: Gautam, Shailendra K., et al.
Publicado: (2023)

A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in Women
por: Henderson, Meredith C, et al.
Publicado: (2018)

Molecular Biomarkers for Early Detection and Prevention of Ovarian Cancer—A Gateway for Good Prognosis: A Narrative Review
por: Yadav, Geetanjali, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c1hrinefnrp9cp5i5a99pda42j